New antibody combo may help people with HIV pause daily pills

NCT ID NCT06031272

First seen Apr 07, 2026 · Last updated May 01, 2026 · Updated 3 times

Summary

This study tests whether giving two lab-made antibodies can safely keep HIV under control when people stop their regular antiretroviral therapy (ART) for a while. About 32 adults with HIV in Sub-Saharan Africa who are already on ART will receive either the antibodies or a placebo by IV. The goal is to see if the antibodies can delay or prevent the virus from rebounding without needing daily pills.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV -1 INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Aurum Institute Klerksdorp CRS (30325)

    Klerksdorp, North West, South Africa

  • Blantyre CRS (30301)

    Blantyre, Malawi

  • CAPRISA eThekwini CRS (31422)

    Durban, KwaZulu-Natal, 4011, South Africa

  • Gaborone CRS (12701)

    Molepolole, Botswana

  • Groote Schuur HIV CRS (31708)

    Cape Town, Western Cape, 7925, South Africa

  • Lilongwe Malawi CRS (12001)

    Lilongwe, Malawi

  • Rustenburg CRS (31684)

    Rustenburg, North West, 0300, South Africa

  • Soweto HVTN CRS (30351)

    Soweto, Gauteng, 1862, South Africa

  • Ward 21 CRS (31966)

    Johannesburg, Gauteng, 2001, South Africa

Conditions

Explore the condition pages connected to this study.